AlgoNomics NV

AlgoNomics’ vision is to employ its advanced proprietary platform in structural bioinformatics tools to develop rationally designed therapeutics in the broad field of immunotherapy. AlgoNomics offers in silico support to companies that develop rationally designed vaccines and therapeutic proteins. AlgoNomics owns a rich, proprietary platform for structure-based protein and peptide design. The technology platform contains biologically validated, innovative tools, which have been developed in-house. These tools add great value in target characterization and lead optimization.